International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Author(s):
Galipeau, J.; Krampera, M.; Barrett, J.; Dazzi, F.; Deans, R.J.; Debruijn, J.; Dominici, M.; Fibbe, W.E. (0000-0001-8539-9011); Gee, A.P.; Gimble, J.M.; Hematti, P.; Koh, M.B.C.; Leblanc, K.; Martin, I.; McNiece, I.K.; Mendicino, M.; Oh, S.; Ortiz, L.; Phinney, D.G.; Planat, V.; Shi, Y.F.; Stroncek, D.F.; Viswanathan, S.; Weiss, D.J.; Sensebe, L.
Published
2016
Publication type
Article / Letter to editor
Mesenchymal Stromal cellspotency assaysrelease assaysmatrix assaysimmune functional testingclinical trialsISCT
Date issued
2016-02-28
Language
English
Is part of
Cytotherapy (2016), Vol. 18, no. 2, p. 151-159
hdl
1887/106994
doi
10.1016/j.jcyt.2015.11.008